Jasleen Pannu, MBBS, discusses the importance of proactive biomarker ordering and close multidisciplinary collaboration in optimal lung cancer care.
Jasleen Pannu, MBBS
Advertisement
Articles by Jasleen Pannu, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Pumitamig Plus Elfetabart Drozuntecan Elicits 70% ORR Across Lines of Therapy in SCLC
2
SERENA-4 Misses Primary PFS End Point With Camizestrant Plus Palbociclib in First-Line ER+ Advanced Breast Cancer
3
Dibotatug Is Safe and Yields Durable Responses in Large Granular Lymphocytic Leukemia
4
Asciminib Maintains Superior MMR and Favorable Safety at 3 Years in Newly Diagnosed Ph+ CML
5